Links to online databases

PubMed
ResearcherID


Biomedical articles under review

10 additional papers currently under review.


Research articles in biomedical journals

[29] Poletti-Muringaseril, S., Rufibach, K., Ruef, C., Holzmann, D., Soyka, M. (2012). Low meningitis-incidence in primary spontaneous compared to secondary cerebrospinal fluid rhinorrhoea. Rhinology, accepted.

[28] Hahn, F., Erschbamer, M., Allenspach, P., Rufibach, K., Schweizer, A. (2012). Physiological bone responses in the fingers after >10 years of high level sport climbing. Wilderness & Environmental Medicine, accepted.

[27] Weber, U., Lambert, R.G.W., Rufibach, K., Maksymowych, W., Hodler, J., Zejden, A., Duewell, S., Kissling, R.O., Filipow, P.L., Jurik, A.G. (2012). Anterior chest wall inflammation by whole body MRI in patients with spondyloarthritis: Lack of association between clinical and imaging findings in a cross-sectional study. Arthritis Res Ther. 14(1), R3. PubMed

[26] Guggenberger, R., Nanz, D., Puippe, G., Rufibach, K., White, L.W., Sussman, M.S., Andreisek, G. (2011). Diffusion tensor imaging of the median nerve: Intra-, inter-reader agreement and agreement between two software packages. Skeletal Radiol., accepted. PubMed

[25] Spross, C., Platz, A., Rufibach, K., Lattmann, T., Forberger, J., Dietrich, M. (2011). The PHILOS Plate for Proximal Humeral Fractures - Risk Factors for Complications at one Year. The Journal of Trauma, Injury, Infection and Critical Care, accepted.

[24] Soyka, M.D., Nikolaoui, G., Rufibach, K., Holzmann, D. (2011). On the effectiveness of treatment options in epistaxis: An analysis on 678 patients. Rhinology, 49(4), 474-478. PubMed

[23] von Websky*, M., Oberkofler*, C.E., Rufibach, K., Raptis, D.A., Lehmann, K., Hahnloser, D., Clavien, P.A. (2011). Modifying the concept of Job Satisfaction for Surgical Training Programs: Modern management tools ensure trainee motivation and success. Surgery, accepted. PubMed

[22] Allenspach P., Saupe N., Rufibach, K., Schweizer A. (2011). Radiological changes and signs of osteoarthritis in the fingers of male performance sportclimbers. J Sports Med Phys Fitness, 51(3), 497-505. PubMed

[21] Jaberg, L., Toggweiler, S., Puck, M., Rufibach, K.,Lüscher, T.F., Corti, R. (2011). The prognostic value of N-terminal proBNP in patients with acute coronary syndromes undergoing left main PCI. Circ J., 75(11), 2648-2653. PubMed

[20] Britschgi, M., Rufibach, K., Bauer Huang, S.L., Clark, C.M., Kaye, J.A., Li, G., Peskind, E.R., Quinn, J.F., Galasko, D.R., Wyss-Coray, T. (2011). Modeling of pathological traits in Alzheimer's disease based on extracellular signaling proteome. Mol Cell Proteomics, 10(10). PubMed

[19] Taegtmeyer, A.B., Curkovic, I., Rufibach, K., Corti, N., Battegay, E., Kullak-Ublick, G.A. (2011). Electronic prescribing increases uptake of clinical pharmacologists' recommendations in the hospital setting. Br. J. Clin. Pharmacol., 72(6), 958-64. PubMed

[18] Steurer-Dober I., Rufibach, K., Hodler, J., Saupe, N., Zanetti, M., Fucentese, S., Pfirrmann, C.W.A. (2010). Do Patients with MR Abnormalities of the Shoulder Experience Pain after MR Arthrography of the Shoulder? Radiology, 256(3), 870-878. PubMed

[17] Thalhammer, C., Ferriani, V., Husmann, M., Rufibach, K., Meier, T., Amann-Vesti, B.R. (2010). Predictive value of duplex ultrasound for restenosis after renal artery stenting. Clin Hemorheol Microcirc., 45, 217-24. PubMed

[16] Sürder, D., Schwitter, J., Moccetti, T., Astori, G., Rufibach, K., Plein, S., Lo Cicero, V., Soncin, S., Windecker, S., Moschovitis, A., Wahl, A., Erne, P., Jamshidi, P., Auf der Maur, C., Manka, R., Soldati, Bühler, I., Wyss, C., G., Landmesser, U., Lüscher, T.F., Corti, R. (2010). Cell-based therapy for myocardial repair in patients with acute myocardial infarction: Rationale and study design of the SWiss multicenter Intracoronary Stem cells Study in Acute Myocardial Infarction (SWISS-AMI). Am Heart J., 160(1), 58-64. PubMed

[15] Soyka, M.B., Rufibach, K., Huber, A., Holzmann, D. (2010). Is Severe Epistaxis Associated With Acetylsalicylic Acid Intake? Laryngoscope, 120(1), 200-207. PubMed

[14] Weber, U., Hodler, J., Jurik, A.G., Pfirrmann, C.W.A., Rufibach, K., Kissling, R.O., Khan, M.A., Lambert, R.G.W., Maksymowych, W.P. (2010). Assessment of acute spinal inflammatory changes in patients with spondyloarthritis: Validation of whole body MRI against conventional MRI. Ann. Rheum. Dis.,69(4), 648-653. PubMed

[13] Nocito, A., Wildi, S., Rufibach, K., Clavien, P.A, Weber, M. (2009). Placement of implantable venous access ports in oncologic surgery: A prospective randomized trial comparing venous cut-down versus Seldinger technique. Br. J. Surg., 96(10), 1129-1134. PubMed

[12] Britschgi, M., Olin, C.E., Johns, H., Takeda-Uchimura, Y., LeMieux, M., Rufibach, K., Rajadas, J., Zhang, H., Tmoooka, B., Robinson, W.H., Clark, C.M., Fagan, A.M., Galasko, D.G., Holtzman, D.M., Jutel, M., Leszek, J., Li, G., Peskind, E.R., Quinn, J.F., Yesavagem, J.A., Ghiso, J.A., and Wyss-Coray, T. (2009). Neuroprotective natural antibodies to assemblies of amyloidogenic peptides decrease with normal aging and advancing Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A., 106(29), 12145-12150. PubMed

[11] Weber, U., Hodler, J., Kubik, R.A., Rufibach, K., Lambert, R.G.W., Kissling, R.O., Pfirmmann, C.W.A, Maksymowych, W.P. (2009). Sensitivity and specificity of spinal inflammatory lesions assessed by whole body MRI in spondyloarthritis and recent-onset inflammatory back pain. Arthritis Rheum., 61(7), 900-–908. PubMed

[10] Weber, U., Maksymowych, W.P., Jurik, A.G., Pfirrmann, C.W.A., Rufibach, K., Kissling, R.O., Khan, M.A., Lambert, R.G.W., Hodler, J. (2009). Validation of whole body MRI against conventional MRI for scoring acute inflammatory lesions in the sacroiliac joints of patients with spondyloarthritis. Arthritis Rheum., 61(7), 893-899. PubMed

[9] Hermanns*, T., Sauermann*, P., Rufibach, K., Frauenfelder, T., Sulser, T., Strebel, R.T. (2009). Is there a role for tamsulosin in the treatment of distal ureteral stones smaller than 7mm? Results of a randomised, double-blind, placebo-controlled trial. Eur. Urol., 56(3), 407-412. PubMed

[8] Furrer, M., Schweizer, A., Rufibach, K., Meuli-Simmen, C. (2009). The value of ultrasonography in handsurgery. Hand, 4(4), 385-90. PubMed

[7] Ruhstaller, T., von Moos, R., Rufibach, K., Ribi, K., Glaus, A., Spaeti, B., Koeberle, D., Mueller, U., Hoefliger, M., Hess, D., Boehme, C., Thuerlimann, B. (2009). Breast Cancer Patients on Endocrine Therapy Reveal More Symptoms when Self-Reporting than in Pivotal Trials: An Outcome Research Study. Oncology, 76(2), 142-–148. PubMed

[6] Münger-Beyeler, C., Bernhard, J., Rufibach, K., Morant, R., Schmid, H.-P. (2008). Quality of analgesic treatment in patients with advanced prostate cancer: Do we do a better job now? The Swiss Group for Clinical Cancer Research (SAKK) Experience. Support. Care Cancer, 16(5), 461-467. PubMed

[5] Roth, A.D., Fazio, N., Stupp, R., Falk, S., Bernhard, J., Saletti, P., Köberle, D., Borner, M.M., Rufibach, K., Maibach, R., Wernli, M., Mainwaring, P., Harrison, M., Widmer, L., Seymour, M., de Braud, F. (2007). Docetaxel-Cisplatin-5FU versus Docetaxel-Cisplatin versus Epirubicin-Cisplatin-5FU as systemic treatment for advanced gastric carcinoma: A randomized phase II trial of the SAKK. J. Clin. Oncol., 25(22), 3217-3223. PubMed

[4] Ribi, K., Bernhard, J., Rufibach, K., Thürlimann, B., von Moos, R., Ruhstaller, T., Glaus, A., Böhme, C. (2007). Endocrine symptom assessment in women with breast cancer: what a simple ``yes'' means. Support. Care Cancer, 15(12), 1349-1356. PubMed

[3] Ghielmini, M., Rufibach, K., Salles, G., Leoncini-Franscini, L., Leger-Falandry, C., Cogliatti, S., Fey, M., Martinelli, G., Stahel, R., Lohri, A., Ketterer, N., Wernli, M., Cerny, T. and Hsu-Schmitz, S. (2005). Single agent rituximab in patients with follicular or mantle cell lymphoma: clinical and biological factors which are predictive of response and event free survival as well as the effect of rituximab on the immune system. Ann. Oncol., 16(10), 1675-1682. PubMed

[2] Taussky, D., Rufibach, K., Huguenin, P., Allal, A. (2005). Risk factors for developing a second aerodigestive cancer after radiotherapy with or without chemotherapy for head and neck cancer: An exploratory outcome analysis. Int. J. Radiat. Oncol. Biol. Phys., 62(3), 684-689. PubMed

[1] Huguenin, P., Beer, K., Allal, A., Rufibach, K., Friedli, C., Davies, B.D., Pestalozzi, B., Schmid, S., Thöni, A., Oszahin, M., Bernier, J., Töpfer, M., Kann, R., Meier, U.R., Thum, P., Bieri, S., Notter, M., Lombriser, N., Glanzmann, C. (2004). Concomitant Cisplatin Significantly Improves Loco-Regional Control in Advanced Head and Neck Cancers Treated with Hyperfractionated Radiotherapy. J. Clin. Oncol., 22(23), 4613-4621. PubMed

* all authors contributed equally


Letters to the editor in biomedical journals

[L3] Rufibach, K. (2010). Use of Brier Score to assess binary predictions. Journal of Clinical Epidemiology, 63(8), 938-939. PubMed

[L2] Zenhäusern, R., von Rohr, A., Rufibach, K., Solenthaler, M., Meyer-Monard, S., Gratwohl, A., Hess, U., Bargetzi, M., Kovacsovic, T., Leoncini, L., Tobler, A. (2009). Low dose 2-chlorodeoxyadenosine given as a single subcutaneous injection in patients with hairy cell leukemia - a multicentre trial SAKK 32/95. Leuk Lymphoma, 50(1), 133-136. PubMed

[L1] Herrmann, R., Lorenz, M., Zuber, M., Rufibach, K., Laffer, U. (2009). Perioperative and adjuvant chemotherapy in colon cancer: results of SAKK trial 40/93. Int J Colorectal Dis., 24(3), 351-352. PubMed


Invited contributions in biomedical journals

[C1] Rufibach, K. (2010). Assessment of paired binary data. Skeletal Radiology, 40(1), 1-4. PubMed



design: ojo3.com